Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology

NCT04451837 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: Semaglutide
DRUG: Dapagliflozin

Sponsor

Region Skane

Collaborators

[object Object]